Overview

Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

Status:
Unknown status
Trial end date:
2009-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Walter Reed Army Medical Center
Treatments:
Apraclonidine
Brimonidine Tartrate
Criteria
Inclusion Criteria:

- male or female, at least 18 years of age

- Open Angle Glaucoma with inadequate intraocular pressure (IOP) control or evidence of
progression (based on optic nerve head appearance and/or visual field changes) despite
current medical therapy

- Ocular Hypertension requiring lowering of IOP

- ability to understand and provide informed consent to participate in this study and
willingness to follow study instructions and likely to complete all required visits

Exclusion Criteria:

- inability to understand and provide informed consent to participate in this study

- inability/unwillingness to follow study instructions and complete all required visits

- Documented allergy to either brimonidine or iopidine

- Angle Closure Glaucoma

- Congenital/Juvenile Glaucoma

- Neovascular Glaucoma

- Active uveitis